1WHO Technical Report Series.WHO Expert Consultation on Rabies 2004[R].First Report.2005,931.
2The Asian Rabies Expert Bureau.Preventing the incurable:Asian rabies experts advocate rabies control[J].Vaccine,2006,24 (16):3045 -3049.
3Henry Wilde,Thiravat Hemachudha.How far can the antigen content of tissue culture rabies vaccine be reduced safely[J].Vaccine,2006,24:1489.
4Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease by blood and blood product,Final FDA guidance document[EB/OL].www.fda.gov/cber/gdlns/cjdvcjdq&a.htm.
5Report of WHO Consultation on Medicinal and Other Products in Relation to Human and Animal Transmissible Spongiform Encephalitis[R].WHO,1997.3.
6Note for guidance on production and quality control of animal immunoglobulins and immunosera for humanse[EB/OL].http://www.emea.eu.int.
7Khawplod P.Wilds H.Chomchey P,et al.What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously[J].Vaccine,1996,14(5):389-391.
